Patents-Review.com
🔗 Permalink
Assignee profile:

BIOTEC PHARMACON ASA

City:

Tromso

Country:

Norway

Published Applications:

20

Last publication date:

2017-03-02

Patent Grants:

17

Last grant date:

2020-05-12

Top Inventors for applications by BIOTEC PHARMACON ASA

These are the the leading inventors for applications assigned to BIOTEC PHARMACON ASA:

Recent patent applications by BIOTEC PHARMACON ASA

BIOTEC PHARMACON ASA based in Tromso, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-03-02 ✅ Patent 10,646,506 granted on 2020-05-12
US20170056433A1
Human necessities

Glucans

 #2 | 2016-12-08 ✅ Patent 9,650,618 granted on 2017-05-16
US20160355798A1
Chemistry; metallurgy

Endonucleases

 #3 | 2016-09-08 ✅ Patent 9,750,688 granted on 2017-09-05
US20160256385A1
Human necessities

Glucan gels

 #4 | 2014-12-18 ✅ Patent 9,422,595 granted on 2016-08-23
US20140370514A1
Chemistry; metallurgy

Endonucleases

 #5 | 2014-04-03 ✅ Patent 9,133,447 granted on 2015-09-15
US20140093938A1
Chemistry; metallurgy

Method of removing nucleic acid contamination in reverse transcription and amplification reactions

 #6 | 2013-11-28 ✅ Patent 9,314,432 granted on 2016-04-19
US20130315979A1
Human necessities

Glucan gels

 #7 | 2013-11-21 ✅ Patent 9,623,043 granted on 2017-04-18
US20130310338A1
Human necessities

Glucans

 #8 | 2013-11-21 ✅ Patent 9,956,245 granted on 2018-05-01
US20130309286A1
Human necessities

Glucan compositions

 #9 | 2013-11-07 ✅ Patent 8,912,165 granted on 2014-12-16
US20130296265A1
Human necessities

Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents

 #10 | 2012-11-22 ✅ Patent 8,946,193 granted on 2015-02-03
US20120295868A1
Human necessities

Medical uses of glucans

 #11 | 2012-01-19
US20120014991A1
Human necessities

NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES

 #12 | 2011-05-05 ✅ Patent 8,252,295 granted on 2012-08-28
US20110104208A1
Human necessities

Enzyme treatment of glucans

 #13 | 2011-01-27 ✅ Patent 8,551,753 granted on 2013-10-08
US20110020878A1
Chemistry; metallurgy

Method of removing nucleic acid contamination in reverse transcription and amplification reactions

 #14 | 2011-01-13
US20110008476A1
Human necessities

Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract

 #15 | 2010-12-23
US20100322923A1
Human necessities

Medical Uses of Glucans

 #16 | 2008-05-29 ✅ Patent 8,142,785 granted on 2012-03-27
US20080124349A1
Human necessities

Method or use of a solubilized glucan product to increase immunostimulation in animals

 #17 | 2006-10-19 ✅ Patent 7,323,325 granted on 2008-01-29
US20060234217A1
Chemistry; metallurgy

Shrimp alkaline phosphatase

 #18 | 2006-05-02 ✅ Patent 7,037,703 granted on 2006-05-02
US9758017
-

COD URACIL-DNA GLYCOSYLASE, GENE CODING THEREFORE, RECOMBINANT DNA CONTAINING SAID GENE OR OPERATIVE PARTS THEREOF, A METHOD FOR PREPARING SAID PROTEIN AND THE USE OF SAID PROTEIN OR SAID OPERATIVE PARTS THEREOF IN MONITORING OR CONTROLLING PCR

 #19 | 2005-10-25 ✅ Patent 6,958,385 granted on 2005-10-25
US10122286
-

Bioactive peptides, uses thereof and process for the production of same

 #20 | 2005-01-13 ✅ Patent 8,501,710 granted on 2013-08-06
US20050009781A1
Human necessities

Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents

Also check out Biotec Pharmacon ASA's (Tromsø, Norway) applicant profile with 6 patent applications submitted.

AssigneeID:

46081 ⎘